Lv2
110 积分 2023-11-08 加入
Does adjuvant treatment improve survival in R1 resected perihilar cholangiocarcinoma? The risk of overtreatment
1天前
已完结
Adjuvant chemotherapy for perihilar cholangiocarcinoma: A population-based comparative cohort study
1个月前
已完结
Adjuvant chemotherapy for perihilar cholangiocarcinoma: A population-based comparative cohort study
1个月前
已完结
Evolving patterns of adjuvant chemotherapy and survival after surgery for peri-hilar cholangiocarcinoma: results from the UK nationwide CAPBIL study
1个月前
已完结
Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation
3个月前
已完结
Single-Agent Immunotherapy for Two Types of Cancer in One Patient
1年前
已完结
How to Determine Unresectability in Hilar Cholangiocarcinoma
1年前
已完结
Update on immunotherapy in the management of gallbladder cancer
1年前
已完结
皖公网安备34019202002308
